Sanofi holds the cleaner structural position, with the lead spread across stability and growth. Biogen still has the edge on valuation, which keeps the comparison from looking entirely one-sided. In the market, Biogen carries the stronger setup — intact trend against Sanofi's broken trend. That leaves a split case: the structural lead stays with Sanofi, but the market is not currently confirming it.
The comparison is based on similar long-term financial trajectories, not sector labels.
The clearest separation starts in stability, but growth adds another real layer to the result. The overall score gap is 20 points in favour of Sanofi.
Both operate in: Drug Manufacturers - General
This comparison is based on industry proximity, not on functional trajectory similarity. BIIB and SAN.PA share the same industry classification.
For a similarity-based comparison, see how Biogen and Sanofi each position within their functional peer groups in AssetNext.
Scores reflect position relative to comparable companies with similar long-term financial trajectories.
The largest gaps do not all point in the same direction.
Left means cheaper relative valuation. Higher means stronger structure.
Sanofi occupies the cheaper side of the setup map, although Biogen Inc. still holds the stronger structural profile.
Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.
The stability gap is very wide, with the stronger side looking materially steadier through time.
Biogen Inc. still shows lower market-fundamental divergence, which keeps the wider picture mixed rather than completely one-sided.
The lead is built on both stability and growth — though valuation still provides a counterweight.
Break down the BIIB vs SAN.PA comparison across all dimensions with the full interactive tool.
Explore how BIIB and SAN.PA each compare against other companies in their peer groups.
Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.